36 Angle-Closure Glaucoma Secondary to Occlusion of the Central Retinal Vein Malik Y. Kahook, MD and David L. Epstein, MD, MMM Occlusion of the central retinal vein is not ordinarily…
18 Management of Highly Elevated Intraocular Pressure Joshua D. Stein, MD, MS; R. Rand Allingham, MD; and Pratap Challa, MD, MS The patient with acutely elevated intraocular pressure (IOP) is…
14 Carbonic Anhydrase Inhibitors Systemic Use Pratap Challa, MD, MS and David L. Epstein, MD, MMM Carbonic anhydrase inhibitors (CAIs) can be useful in the treatment of all the glaucomas…
29 Principles of Secondary Angle-Closure Glaucomas David L. Epstein, MD, MMM In Chapter 23, the mechanisms underlying the primary angle-closure glaucomas were discussed. The fundamental concept was that of pupillary…
28 The Use of Special Tests in Narrow-Angled Eyes Joel S. Schuman, MD, FACS; Rachel L. Anderson, MD; and David L. Epstein, MD, MMM Surgical iridectomy carried significant risk, and…
25 Subacute (and Chronic) Angle-Closure Glaucoma Jeffrey R. SooHoo, MD; David L. Epstein, MD, MMM; and George Ulrich, MD, FACS The principles underlying the pathogenesis, diagnosis, and treatment of subacute…
12 Adrenergic Agents Blockers and Agonists Pratap Challa, MD, MS and David L. Epstein, MD, MMM Topical beta-blockers decrease aqueous humor formation (AHF)1,2 and are used long term in the…
15 Topical Carbonic Anhydrase Inhibitors Pratap Challa, MD, MS and Joel S. Schuman, MD, FACS Carbonic anhydrase inhibitors (CAIs) have been used for glaucoma therapy since 1954, following the description…
16 Prostaglandin Analogs Angela Turalba, MD, MMS and Douglas J. Rhee, MD Unoprostone was the first commercially available prostaglandin analog (PGA) and was introduced in the mid-1990s. Latanoprost, bimatoprost, and…
